| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |